To Acquire Sanofi's Product Portfolio for €158 Million
Gujarat Themis Biosyn Limited · GUJTHEM · NSE ·
The company has entered into an agreement to acquire a portfolio of 13 branded generic products from Sanofi for a cash consideration of <b>€158 million</b> (approx. ₹1740 Crores). This acquisition provides immediate access to over 55 countries, significantly expanding the company…